﻿<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss xmlns:media="http://search.yahoo.com/mrss/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0">
  <channel>
    <atom:link href="http://www.genengnews.com/media/files/rss/TRANSLATIONAL-MEDICINE-therapeutics.xml" rel="self" type="application/rss+xml" />
    <title>Genetic Engineering &amp; Biotechnology News - Therapeutics</title>
    <description>All the latest news on therapeutic drugs and vaccines.</description>
    <lastBuildDate>Fri, 03 May 2013 12:11:41 -0400</lastBuildDate>
    <link>http://www.genengnews.com/media/files/rss/TRANSLATIONAL-MEDICINE-therapeutics.xml</link>
    <item>
      <title>Regeneron Gains Full Rights to Ophthalmology Antibodies from Sanofi</title>
      <link>http://www.genengnews.com/gen-news-highlights/regeneron-gains-full-rights-to-ophthalmology-antibodies-from-sanofi/81248319/</link>
      <description></description>
      <guid>http://www.genengnews.com/gen-news-highlights/regeneron-gains-full-rights-to-ophthalmology-antibodies-from-sanofi/81248319/</guid>
      <pubDate>Fri, 03 May 2013 00:00:00 -0400</pubDate>
      <media:thumbnail url="http://www.genengnews.com/media/images/newsletters/genlogo_red.gif" />
    </item>
  </channel>
</rss>